GlassScriptPhysician profile
Megan Bock
NPI 1205356722
$27,672.76
in general payments reported to CMS, 2019-2025
28 companies · $26K in 2025
The $26K reported for 2025 was more than what 97% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.68 · 2021: $67.60 · 2022: $655 · 2023: $797 · 2024: $384 · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $25K · Food and Beverage: $1,915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $25,000.00 |
| Food and Beverage | $1,914.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25,946.92 | 2019-2025 | General - Therapies, Ams 700, Lumenis Pulse 120h |
| Cook Medical LLC | $234.26 | 2025 | Litho 150 |
| Astellas Pharma US INC | $226.56 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $201.17 | 2023-2024 | Gemtesa, Orgovyx |
| Pfizer INC. | $154.73 | 2022-2024 | |
| Axonics, INC. | $119.38 | 2022-2023 | Axonics, Bulkamid |
| Ambu INC. | $91.91 | 2025 | |
| Endo Pharmaceuticals INC. | $65.35 | 2022-2023 | Aveed, Xiaflex |
| Antares Pharma, INC. | $65.04 | 2023 | Tlando, Xyosted, Nocdurna |
| Tolmar, INC. | $59.52 | 2023-2024 | |
| Myriad Genetic Laboratories, INC. | $57.99 | 2024-2025 | Prolaris |
| Urovant Sciences INC | $46.70 | 2022 | |
| Sun Pharmaceutical Industries INC. | $45.50 | 2023 | Yonsa |
| Koelis INC. | $38.47 | 2023-2024 | |
| Janssen Biotech, INC. | $37.42 | 2023 | Erleada |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $33.05 | 2025 | Cvac Aspiration System |
| Ferring Pharmaceuticals INC. | $27.95 | 2022 | |
| Coloplast Corp | $27.13 | 2022 | |
| Conmed Corporation | $26.88 | 2024 | Airseal |
| Blue Earth Diagnostics | $25.78 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $21.57 | 2022 | |
| Alnylam Pharmaceuticals INC. | $20.65 | 2022 | |
| Olympus America INC. | $18.48 | 2023 | Olympus |
| Accord Healthcare, INC. | $17.47 | 2023 | |
| Foundation Medicine, INC. | $16.83 | 2023 | |
| Teleflex LLC | $16.76 | 2024 | Urolift |
| Mission Pharmacal Company | $14.67 | 2023 | Lithostat |
| Hologic Sales and Service, LLC | $14.62 | 2024 | Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Bock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.